Cite
HARVARD Citation
Geiger, M. et al. (n.d.). Clinical Development Approaches and Statistical Methodologies to Prospectively Assess the Cardiovascular Risk of New Antidiabetic Therapies for Type 2 Diabetes. Therapeutic innovation & regulatory science. pp. 50-64. [Online].